Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden

prnewswire

Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden – NEWSnet – News… as it used to be

More Press Releases

Featured image for Auto-prepared featured image

May 8, 2026

Photonic Integrated Circuit Market to Reach USD 60.3 Billion by 2034, Growing at a CAGR of 15.47%

May 8, 2026

Buy Now Pay Later Market Size to Surpass USD 66.7 Billion by 2034, at a CAGR of 20.75%

May 8, 2026

Sagtec Global Limited Strengthens Smart Property Development Collaboration Following Stateight Sdn Bhd’s Industry Recognition

May 8, 2026

Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden

Photonic Integrated Circuit Market to Reach USD 60.3 Billion by 2034, Growing at a CAGR of 15.47%

Buy Now Pay Later Market Size to Surpass USD 66.7 Billion by 2034, at a CAGR of 20.75%

Sagtec Global Limited Strengthens Smart Property Development Collaboration Following Stateight Sdn Bhd’s Industry Recognition

illumin Reports First Quarter 2026 Financial Results